GO:0032991 | protein-containing complex | 39.22% (20/51) | 1.67 | 1e-06 | 0.001546 |
GO:0018193 | peptidyl-amino acid modification | 15.69% (8/51) | 2.59 | 4.8e-05 | 0.013372 |
GO:0005515 | protein binding | 66.67% (34/51) | 0.82 | 2.9e-05 | 0.013416 |
GO:0042981 | regulation of apoptotic process | 13.73% (7/51) | 2.87 | 4.5e-05 | 0.015761 |
GO:0016604 | nuclear body | 13.73% (7/51) | 2.98 | 2.7e-05 | 0.019071 |
GO:0036211 | protein modification process | 29.41% (15/51) | 1.53 | 0.000114 | 0.026589 |
GO:0043228 | non-membrane-bounded organelle | 25.49% (13/51) | 1.53 | 0.000375 | 0.027512 |
GO:0043232 | intracellular non-membrane-bounded organelle | 25.49% (13/51) | 1.53 | 0.000375 | 0.027512 |
GO:0051641 | cellular localization | 21.57% (11/51) | 1.87 | 0.000158 | 0.027552 |
GO:0065007 | biological regulation | 62.75% (32/51) | 0.77 | 0.00014 | 0.027832 |
GO:0042352 | GDP-L-fucose salvage | 1.96% (1/51) | 9.58 | 0.001305 | 0.028439 |
GO:0047341 | fucose-1-phosphate guanylyltransferase activity | 1.96% (1/51) | 9.58 | 0.001305 | 0.028439 |
GO:0050201 | fucokinase activity | 1.96% (1/51) | 9.58 | 0.001305 | 0.028439 |
GO:0031153 | slug development involved in sorocarp development | 1.96% (1/51) | 9.58 | 0.001305 | 0.028439 |
GO:0150012 | positive regulation of neuron projection arborization | 1.96% (1/51) | 9.58 | 0.001305 | 0.028439 |
GO:1905492 | positive regulation of branching morphogenesis of a nerve | 1.96% (1/51) | 9.58 | 0.001305 | 0.028439 |
GO:2000172 | regulation of branching morphogenesis of a nerve | 1.96% (1/51) | 9.58 | 0.001305 | 0.028439 |
GO:0071528 | tRNA re-export from nucleus | 1.96% (1/51) | 9.58 | 0.001305 | 0.028439 |
GO:0007634 | optokinetic behavior | 1.96% (1/51) | 9.58 | 0.001305 | 0.028439 |
GO:0060036 | notochord cell vacuolation | 1.96% (1/51) | 9.58 | 0.001305 | 0.028439 |
GO:0030892 | mitotic cohesin complex | 1.96% (1/51) | 9.58 | 0.001305 | 0.028439 |
GO:0004057 | arginyltransferase activity | 1.96% (1/51) | 9.58 | 0.001305 | 0.028439 |
GO:0021796 | cerebral cortex regionalization | 1.96% (1/51) | 9.58 | 0.001305 | 0.028439 |
GO:0001109 | promoter clearance during DNA-templated transcription | 1.96% (1/51) | 9.58 | 0.001305 | 0.028439 |
GO:0001111 | RNA polymerase II promoter clearance | 1.96% (1/51) | 9.58 | 0.001305 | 0.028439 |
GO:0001112 | DNA-templated transcription open complex formation | 1.96% (1/51) | 9.58 | 0.001305 | 0.028439 |
GO:0001113 | transcription open complex formation at RNA polymerase II promoter | 1.96% (1/51) | 9.58 | 0.001305 | 0.028439 |
GO:0001120 | protein-DNA complex remodeling | 1.96% (1/51) | 9.58 | 0.001305 | 0.028439 |
GO:0003972 | RNA ligase (ATP) activity | 1.96% (1/51) | 9.58 | 0.001305 | 0.028439 |
GO:0008452 | RNA ligase activity | 1.96% (1/51) | 9.58 | 0.001305 | 0.028439 |
GO:0042245 | RNA repair | 1.96% (1/51) | 9.58 | 0.001305 | 0.028439 |
GO:2000643 | positive regulation of early endosome to late endosome transport | 1.96% (1/51) | 9.58 | 0.001305 | 0.028439 |
GO:0009889 | regulation of biosynthetic process | 29.41% (15/51) | 1.2 | 0.001353 | 0.028602 |
GO:0008104 | protein localization | 15.69% (8/51) | 1.88 | 0.001341 | 0.028774 |
GO:0050789 | regulation of biological process | 58.82% (30/51) | 0.81 | 0.000187 | 0.029057 |
GO:0019538 | protein metabolic process | 33.33% (17/51) | 1.31 | 0.000233 | 0.029547 |
GO:0005488 | binding | 74.51% (38/51) | 0.57 | 0.000318 | 0.029614 |
GO:0097708 | intracellular vesicle | 17.65% (9/51) | 1.72 | 0.001424 | 0.029646 |
GO:0005768 | endosome | 15.69% (8/51) | 2.17 | 0.000365 | 0.029915 |
GO:0006473 | protein acetylation | 7.84% (4/51) | 3.77 | 0.000216 | 0.03014 |
GO:0099023 | vesicle tethering complex | 5.88% (3/51) | 4.47 | 0.000347 | 0.030274 |
GO:0006892 | post-Golgi vesicle-mediated transport | 5.88% (3/51) | 3.74 | 0.001493 | 0.030629 |
GO:0043170 | macromolecule metabolic process | 45.1% (23/51) | 1.01 | 0.000264 | 0.03073 |
GO:0010941 | regulation of cell death | 13.73% (7/51) | 2.03 | 0.001525 | 0.030828 |
GO:0050794 | regulation of cellular process | 52.94% (27/51) | 0.86 | 0.000317 | 0.031588 |
GO:0043543 | protein acylation | 7.84% (4/51) | 3.48 | 0.000462 | 0.032214 |
GO:0031982 | vesicle | 19.61% (10/51) | 1.73 | 0.000686 | 0.032999 |
GO:1902494 | catalytic complex | 17.65% (9/51) | 1.86 | 0.000714 | 0.033178 |
GO:0043412 | macromolecule modification | 29.41% (15/51) | 1.3 | 0.00068 | 0.03386 |
GO:0018205 | peptidyl-lysine modification | 9.8% (5/51) | 3.07 | 0.000316 | 0.033919 |
GO:0060255 | regulation of macromolecule metabolic process | 35.29% (18/51) | 1.16 | 0.000524 | 0.034777 |
GO:0043067 | regulation of programmed cell death | 13.73% (7/51) | 2.28 | 0.000551 | 0.034928 |
GO:0010556 | regulation of macromolecule biosynthetic process | 27.45% (14/51) | 1.36 | 0.000679 | 0.035064 |
GO:0032502 | developmental process | 49.02% (25/51) | 0.86 | 0.000655 | 0.035119 |
GO:0051171 | regulation of nitrogen compound metabolic process | 31.37% (16/51) | 1.11 | 0.001772 | 0.035306 |
GO:0140513 | nuclear protein-containing complex | 15.69% (8/51) | 2.04 | 0.000639 | 0.035641 |
GO:0045202 | synapse | 9.8% (5/51) | 2.86 | 0.000621 | 0.036109 |
GO:0007034 | vacuolar transport | 7.84% (4/51) | 3.37 | 0.000609 | 0.036909 |
GO:0006354 | DNA-templated transcription elongation | 3.92% (2/51) | 4.97 | 0.001887 | 0.037081 |
GO:0006508 | proteolysis | 13.73% (7/51) | 1.95 | 0.002055 | 0.039276 |
GO:0019222 | regulation of metabolic process | 37.25% (19/51) | 0.95 | 0.002039 | 0.039497 |
GO:0016755 | aminoacyltransferase activity | 3.92% (2/51) | 5.3 | 0.001199 | 0.04182 |
GO:0031589 | cell-substrate adhesion | 3.92% (2/51) | 5.26 | 0.001261 | 0.04189 |
GO:0006807 | nitrogen compound metabolic process | 49.02% (25/51) | 0.81 | 0.001119 | 0.042207 |
GO:0005770 | late endosome | 5.88% (3/51) | 3.45 | 0.002633 | 0.042708 |
GO:0018394 | peptidyl-lysine acetylation | 5.88% (3/51) | 3.45 | 0.002633 | 0.042708 |
GO:0048523 | negative regulation of cellular process | 27.45% (14/51) | 1.29 | 0.001105 | 0.042831 |
GO:0080090 | regulation of primary metabolic process | 33.33% (17/51) | 1.1 | 0.00126 | 0.042873 |
GO:0070647 | protein modification by small protein conjugation or removal | 13.73% (7/51) | 2.09 | 0.001199 | 0.042875 |
GO:0031410 | cytoplasmic vesicle | 17.65% (9/51) | 1.76 | 0.001171 | 0.04299 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 9.8% (5/51) | 2.38 | 0.002699 | 0.043276 |
GO:0048522 | positive regulation of cellular process | 31.37% (16/51) | 1.18 | 0.001027 | 0.043399 |
GO:1990234 | transferase complex | 11.76% (6/51) | 2.09 | 0.002776 | 0.043505 |
GO:0070727 | cellular macromolecule localization | 15.69% (8/51) | 1.72 | 0.002627 | 0.043635 |
GO:0031326 | regulation of cellular biosynthetic process | 29.41% (15/51) | 1.25 | 0.000971 | 0.043709 |
GO:0019941 | modification-dependent protein catabolic process | 9.8% (5/51) | 2.37 | 0.002762 | 0.04379 |
GO:0016598 | protein arginylation | 1.96% (1/51) | 8.58 | 0.002608 | 0.04383 |
GO:0004832 | valine-tRNA ligase activity | 1.96% (1/51) | 8.58 | 0.002608 | 0.04383 |
GO:0006438 | valyl-tRNA aminoacylation | 1.96% (1/51) | 8.58 | 0.002608 | 0.04383 |
GO:0046548 | retinal rod cell development | 1.96% (1/51) | 8.58 | 0.002608 | 0.04383 |
GO:2000641 | regulation of early endosome to late endosome transport | 1.96% (1/51) | 8.58 | 0.002608 | 0.04383 |
GO:0005856 | cytoskeleton | 9.8% (5/51) | 2.7 | 0.001005 | 0.043832 |
GO:0048519 | negative regulation of biological process | 33.33% (17/51) | 1.12 | 0.0011 | 0.04385 |
GO:0007155 | cell adhesion | 5.88% (3/51) | 3.9 | 0.001087 | 0.044607 |
GO:0000151 | ubiquitin ligase complex | 7.84% (4/51) | 2.75 | 0.002963 | 0.044928 |
GO:0030665 | clathrin-coated vesicle membrane | 3.92% (2/51) | 4.65 | 0.002908 | 0.045069 |
GO:0016070 | RNA metabolic process | 17.65% (9/51) | 1.56 | 0.002947 | 0.045184 |
GO:0016573 | histone acetylation | 5.88% (3/51) | 3.48 | 0.002494 | 0.046383 |
GO:0048513 | animal organ development | 11.76% (6/51) | 2.05 | 0.003093 | 0.046389 |
GO:0006475 | internal protein amino acid acetylation | 5.88% (3/51) | 3.46 | 0.002598 | 0.046458 |
GO:0018393 | internal peptidyl-lysine acetylation | 5.88% (3/51) | 3.46 | 0.002598 | 0.046458 |
GO:0051253 | negative regulation of RNA metabolic process | 13.73% (7/51) | 1.91 | 0.002469 | 0.046546 |
GO:0005575 | cellular_component | 80.39% (41/51) | 0.4 | 0.002548 | 0.046767 |
GO:0008150 | biological_process | 80.39% (41/51) | 0.39 | 0.003172 | 0.047073 |
GO:0043632 | modification-dependent macromolecule catabolic process | 9.8% (5/51) | 2.32 | 0.003219 | 0.047274 |
GO:0005769 | early endosome | 5.88% (3/51) | 3.33 | 0.003318 | 0.047725 |
GO:0016605 | PML body | 3.92% (2/51) | 4.56 | 0.003294 | 0.047865 |
GO:0033365 | protein localization to organelle | 9.8% (5/51) | 2.29 | 0.003534 | 0.049297 |
GO:0051252 | regulation of RNA metabolic process | 23.53% (12/51) | 1.25 | 0.003518 | 0.049569 |
GO:0006896 | Golgi to vacuole transport | 3.92% (2/51) | 4.49 | 0.003598 | 0.049702 |
GO:0044238 | primary metabolic process | 50.98% (26/51) | 0.68 | 0.003503 | 0.049861 |